US Patent 11918689 Liquid clonidine extended release composition
Patent 11918689 was granted and assigned to Tris Pharma on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+32 properties)
Article (+413 characters)
US Patent 11918689 Liquid clonidine extended release composition
Article
Patent abstract
An oral clonidine dosage unit providing a twenty-four hour extended release profile following a single dose administration is provided. The dosage unit comprises a pharmaceutically effective amount of a coated complex comprising clonidine bound to a cationic exchange resin, which is characterized by a twenty-four hour release profile. Dosage units may also provide an immediate release component.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Grishma Patel0
Date of Patent
March 5, 2024
0Patent Application Number
173875170
Date Filed
July 28, 2021
0Patent Citations
0
Patent Primary Examiner
Find more entities like US Patent 11918689 Liquid clonidine extended release composition
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
